USFDA approves IND application from Reven Pharma for Rejuveinix to treat COVID-19
RJX is an IV formulation being developed for treatment of inflammatory disorders, including COVID-19 patients with viral sepsis,…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.